Clinical & Experimental AllergyVolume 4, Issue 1 p. 1-12 A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation, Corresponding Author A Hong Kong Tuberculosis Treatment Services/British Medical Research Council InvestigationMRC Tuberculosis and Chest Diseases Unit, Brompton Hospital, Fulham Road, London, SW3 6HP, or to Dr W. G. L. Allan, Wanchai Chest Clinic, Kennedy Road, Wanchai, Hong Kong.Search for more papers by this author A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation, Corresponding Author A Hong Kong Tuberculosis Treatment Services/British Medical Research Council InvestigationMRC Tuberculosis and Chest Diseases Unit, Brompton Hospital, Fulham Road, London, SW3 6HP, or to Dr W. G. L. Allan, Wanchai Chest Clinic, Kennedy Road, Wanchai, Hong Kong.Search for more papers by this author First published: March 1974 https://doi.org/10.1111/j.1365-2222.1974.tb01357.xCitations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume4, Issue1March 1974Pages 1-12 RelatedInformation